AnodyneWiki

Secobarbital

Secobarbital
Secobarbital
Salts
[]
Sodium secobarbital
Sodium secobarbital
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass238.28 g/mol [1]
AppearanceWHITE, AMORPHOUS OR CRYSTALLINE POWDER [1]
OdorODORLESS [1]
TasteSlightly bitter [1]
Melting point100 °C [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1]
Solubility550 mg/L [1]
Predicted LogP2 [1]
Structural Identifiers
[]
Molecular formulaC12H18N2O3
IUPAC name5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
SMILESCCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C
InChIInChI=1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)
InChIKeyKQPKPCNLIDLUMF-UHFFFAOYSA-N
CAS number76-73-3
UNII1P7H87IN75
PubChem CID5193
Pharmacokinetics[]
Elimination half-life15–40 hours[3]
MetabolismHepatic
ExcretionRenal
Routes of administrationBy mouth, intravenous
Dependence liabilityHigh
Addiction liabilityHigh
Toxicity
[]
Mouse:
- oral: 267 mg/kg
- ip: 116 mg/kg
Rat:
- oral: 125 mg/kg /Secobarbital
- iv: 65 mg/kg /Seconal
 [1]

Secobarbital (also known as Secobarbitone, Quinalbarbitone, Seconal, Quinalbarbital, Evronal, Hypotrol, Meballymal, Immenox, Secobarbitalum or Somosal) is a substance of the barbiturate class.

Chemistry

Salts []

Secobarbital is typically found in the form of its sodium salt.

 []

Secobarbital is a racemic mixture of the (optical activity ( + / - )).

Secobarbital matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Secobarbital binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA<sub>A</sub> receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32
shared target32

Medical side effects []

38 side effects listed on drug labels in (secobarbital).

  • Anaemia megaloblastic
  • Angioedema
  • Anxiety
  • Apnoea
  • Ataxia
  • Confusional state
  • Feeling abnormal
  • Constipation
  • Dermatitis exfoliative
  • Dizziness
  • Syncope
  • Dermatitis
  • Rash
  • Body temperature increased
  • Hallucination
  • Headache
  • Hypersensitivity
  • Hypotension
  • Nausea
  • Nervousness
  • Tension
  • Nightmare
  • Shock
  • Loss of consciousness
  • Vomiting
  • Agitation
  • Hyperkinesia
  • Depressed level of consciousness
  • Injection site reaction
  • Hepatocellular injury
  • Liver injury
  • Thinking abnormal
  • Mental disability
  • Bradycardia
  • Somnolence
  • Hypoxia
  • Respiratory failure
  • Hypoventilation

Indications

  • Insomnia

 []

  • Brazil: Secobarbital is a B1.[4]
  • Canada: Secobarbital is a Schedule IV.
  • Germany: Secobarbital is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
  • United States: Secobarbital is a Schedule II except when combined in a dosage unit with another active drug (in which case Schedule III) under the "Controlled Substances Act".
  • United Kingdom: Secobarbital is a Class B under the "Misuse of Drugs Act 1971".
  • United Nations: Secobarbital is a Schedule II psychotropic under the "Convention on Psychotropic Substances 1971".

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5193, Secobarbital. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5193
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Secobarbital. UNII: 1P7H87IN75. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/1P7H87IN75
  3. Secobarbital. http://www.merck.com/mmpe/lexicomp/secobarbital.html
  4. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 16:33:40
drugspromissing (no DrugsPRO reagent data)2026-11-20 16:33:36
erowidmissing (no Erowid substance of that name)2026-11-20 16:33:35
gsrsok2026-11-20 16:33:37
hmdbmissing (hmdb.ca refused automated access to HMDB0014562)2026-11-20 16:33:35
keggok2026-11-20 16:33:38
pubchemok2026-11-20 16:33:34
redditmissing (no r/tripreports posts mention it)2026-11-20 16:33:35
siderok2026-11-20 16:33:36
structureok2026-11-20 16:33:35
wikipediaok2026-11-20 16:33:36